Clin2
NCT02097706Possibly a fitRecruiting

Drug study for borderline personality disorder

Borderline Personality Disorder

Part of Mental health clinical trials.

This Phase 2 study tests a new medicine for people with borderline personality disorder (BPD) to see if it can improve symptoms. You may qualify if you have a confirmed BPD diagnosis and meet safety and medication rules.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You’re between 18 and 65 years old
  • You have a current diagnosis of borderline personality disorder (BPD), or meet BPD score cutoffs from study interviews
  • You can read and write English well enough for the study
  • You do not have serious medical problems that affect the liver, kidneys, blood, or heart
  • You are not taking certain brain-acting medicines (like ketamine, amantadine, or similar) and your medication setup fits the study rules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06683014Recruiting· Phase 2
MDMA study for borderline personality disorder

This trial tests if a single dose of MDMA, given under supervision, can help people with borderline personality disorder (BPD). You will stay overnight after the session and be followed up for two weeks.

New Haven, Connecticut
NCT07337889Recruiting
Borderline personality as a relationship disorder study

This study compares people with borderline personality disorder, bipolar disorder, and healthy controls to understand how relationships are affected. It may help find better ways to support people with these conditions.

Montpellier
NCT06759298Not yet recruiting· Early Phase 1
Methylphenidate for borderline personality disorder symptoms

This trial tests whether the medication methylphenidate (brand name Concerta) can help reduce symptoms like impulsivity and mood swings in people with borderline personality disorder. Methylphenidate is typically used for ADHD but may affect brain chemicals related to impulse control.

NCT05942651Recruiting
tMS for impulsivity in borderline personality disorder

This trial studies whether magnetic brain stimulation (tMS) can reduce impulsive symptoms in people with borderline personality disorder. It may help by changing how brain networks involved in impulse control work.

Bron, AURA
NCT06626789Recruiting· Phase 1/Phase 2
Brain signal training to help regulate emotions

This study tests a new brain-training technique that may help people with borderline personality disorder manage their emotions better. You will do mental exercises while an MRI scans your brain, and the results will show whether this training can reduce emotional distress.

Freiburg im Breisgau
NCT06493708Recruiting
EMDR Therapy for Borderline Personality Disorder

This study tests whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can help people with Borderline Personality Disorder (BPD). EMDR is a type of talk therapy often used for trauma, and this trial wants to see if it can improve BPD symptoms.

Brescia, Brescia

Hear when a new Borderline Personality Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.